| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/28/2007 | EP1765791A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 03/28/2007 | EP1765769A1 Process for the preparation of nateglinide |
| 03/28/2007 | EP1765765A1 Arylalkylamine vanadium (v) salts for the treatment and/or prevention of diabetes mellitus |
| 03/28/2007 | EP1765760A1 Phenyl derivatives comprising an acetylene group |
| 03/28/2007 | EP1765408A2 Polypeptide protracting tags comprising a tetrazole moiety |
| 03/28/2007 | EP1765324A2 Compositions of stable bioactive metabolites of docosahexaenoic (dha) and eicosapentaenoic (epa) acids |
| 03/28/2007 | EP1765323A1 Use of furan alkyl for preparing an antidiabetic drug |
| 03/28/2007 | EP1765320A2 Use of ppar agonists to treat ruminants |
| 03/28/2007 | EP1765311A2 Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
| 03/28/2007 | EP1545552B1 Combination therapy wherein a serotonin reuptake inhibitor is used |
| 03/28/2007 | EP1497294B1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 03/28/2007 | EP1414470B1 Micronutrient phosphates as dietary and health supplements |
| 03/28/2007 | EP1152760B1 Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 03/28/2007 | CN1938334A Combined use of a GLP-1 agonist and gastrin compounds |
| 03/28/2007 | CN1938320A Compounds and methods for treating dyslipidemia |
| 03/28/2007 | CN1938317A Adiponectin increasing agent |
| 03/28/2007 | CN1938314A Tetrahydroquinoline derivatives and a process for preparing the same |
| 03/28/2007 | CN1938308A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 03/28/2007 | CN1938305A 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof |
| 03/28/2007 | CN1938300A Oxadiazolone derivatives as PPAR delta agonists |
| 03/28/2007 | CN1938287A Phenoxyacetic acid derivative and medicine containing the same |
| 03/28/2007 | CN1938043A Y2/Y4 selective receptor agonists for therapeutic interventions |
| 03/28/2007 | CN1938024A Combination of a heterocyclic compound and an antioxidant and use thereof for treating obesity |
| 03/28/2007 | CN1938018A Use of compounds that are able to increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level |
| 03/28/2007 | CN1935846A Fusion protein for treating diabetes, and its preparing method and use |
| 03/28/2007 | CN1935839A Analogues of glp-1 |
| 03/28/2007 | CN1935787A Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 03/28/2007 | CN1935261A Medicine composition for preventing and treating diabetes mellitus and its use |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935247A Medicinal composition for treating adiposis or hyperlipemia |
| 03/28/2007 | CN1935246A Yin-nourishing sugar-reducing capsule for treating type II diabetes |
| 03/28/2007 | CN1935243A Natural fermented preparation of rice |
| 03/28/2007 | CN1935216A Composition containing gynostemma pentaphylla total aglycone and tea polyphenol |
| 03/28/2007 | CN1935213A Use of total saponinof sapindusmukeossi for preparing clinical medicine |
| 03/28/2007 | CN1935207A Composition for preventing and treating hyper blood fat and cardio-cerebrovascular diseases |
| 03/28/2007 | CN1935199A Quality control method for Chinese medicine compound preparation |
| 03/28/2007 | CN1935186A Compound perillaseed oil and its capsule pill |
| 03/28/2007 | CN1935179A Fat-regulating medicinal composition from Tibetanmedicine and its preparing method |
| 03/28/2007 | CN1935178A Ginkgo leaf extract and barrenwort extract composition |
| 03/28/2007 | CN1935167A Water fennel total phenolic acid preparing process, and medicinal preparation using same as active component and use |
| 03/28/2007 | CN1935153A Lyophilized powder injection containing three B-vitamins and its preparing method |
| 03/28/2007 | CN1935151A Weight-reducing medicine or health product |
| 03/28/2007 | CN1935149A Medicinal composition and its preparing method |
| 03/28/2007 | CN1935141A Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 03/28/2007 | CN1935125A Pharmaceutical composition for modified release insulin sensitiser |
| 03/28/2007 | CN1307190C Crystals of glucopyranosyloxybenzyl benzene derivative |
| 03/28/2007 | CN1307184C Double(2-ethyl -3-hydroxyl-4-pyranone)copper(ó�)complex and its uses in treating diabetes |
| 03/28/2007 | CN1307183C Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307171C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 03/28/2007 | CN1307166C Oxazole/thiazol-derivatives activators of the HPPAR-alpha receptor |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/28/2007 | CN1307156C Polyarylcarboxamides useful as lipid lowering agents |
| 03/28/2007 | CN1307147C 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 03/28/2007 | CN1306954C Use of a pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention |
| 03/28/2007 | CN1306931C Capsule preparation |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases |
| 03/27/2007 | US7196107 Thia-and oxazoles and their use as ppars activators |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | US7196065 Enteral formulation |
| 03/27/2007 | US7195914 Composition and method for treatment of hypertriglyceridemia |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195886 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 03/27/2007 | US7195791 Method for production of archidonic acid |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | US7195675 Chitosan-containing polysaccharide, method for preparing the same and use thereof |
| 03/27/2007 | CA2399976C Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/27/2007 | CA2168879C Skin patches and methods for providing testosterone |
| 03/27/2007 | CA2019580C Novel methods of treatment using ranolazine and related piperazine derivatives |
| 03/22/2007 | WO2007033350A1 Dipeptidyl peptidase inhibitors for treating diabetes |
| 03/22/2007 | WO2007033266A2 Dipeptidyl peptidase inhibitors for treating diabetis |
| 03/22/2007 | WO2007033265A1 Dipeptidyl peptidase inhibitors for treating diabetis |
| 03/22/2007 | WO2007033112A1 Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
| 03/22/2007 | WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| 03/22/2007 | WO2007032557A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032536A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2007032371A1 Oxindole derivative as feeding control agent |
| 03/22/2007 | WO2007032340A1 COMPOSITION CONTAINING α-LIPOIC ACID |
| 03/22/2007 | WO2007032028A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 03/22/2007 | WO2007032013A2 Compounds for improving nutritional status, cognition and survival |
| 03/22/2007 | WO2007031801A1 IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF |
| 03/22/2007 | WO2007031739A1 Heterobicyclic compounds as glucokinase activators |
| 03/22/2007 | WO2007031721A1 Midazole-4-carboxamide derivatives for use as cb modulators |
| 03/22/2007 | WO2007031291A2 Foodstuff additive |
| 03/22/2007 | WO2007016353A3 Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists |
| 03/22/2007 | WO2007015004A3 Novel crystalline v form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 03/22/2007 | WO2006113978A3 Insulins combinations |
| 03/22/2007 | WO2006086562A3 Phenylazetidinone derivatives |
| 03/22/2007 | WO2006079021A3 Use of sirtuin-activating compounds for treating flushing and drug induced weight gain |
| 03/22/2007 | WO2006016424A8 Preventive and/or therapeutic agent for calcipenia |
| 03/22/2007 | US20070067861 Cloning pigs using donor nuclei from differentiated cells |